Herantis Pharma Reveals Strong Biological Response To HER-096
07 Jan 2026 //
GLOBENEWSWIRE
Herantis Pharma Completes 6-Month GLP Toxicology Study On HER-096
26 Nov 2025 //
GLOBENEWSWIRE
Herantis Pharma Unveils Positive Phase 1B Data For HER-096
07 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support